Yeah ....but so are Bell Potter and their views were posted by Benelong.
03/06/16Time:15:28:38Post #: 17946056
With TEVA, from my perspective , worst case scenario (which I dont believe will transpire based , remarkable, astonishing results to date, understanding the hindsight of what it means when there is a "hockey stick" impact in recruiting + 121 locations now updated on Clinical trials.com and on potential contributions to GP by Revacsor chf alone - see current Teva GP ), if they were to concentrate on Generics... if would be unconscionable to think they wouldn't transfer the ceph/teva MPC licences for $$$$.
Via Lonza manufacturing, I think the Cogs to Teva are b/w 30-35%, thereby producing a GP margin of ~70% to ~65 %....no comparison to generics GP margin of 46%. Also, in good time, the cogs come down with scale.
A tale of two cities (extract from article)
Teva is a story of two business models: a generic business that is diversified across many drugs but is less profitable, and a specialty drug business that is more profitable but also heavily dependent on the success of the multiple sclerosis drug Copaxone.
Q1 2016 numbers. Source: TEVA Pharmaceuticals
Column 1 Column 2 Column 3 Column 4 Column 5 0 Division Revenue Gross margin Segment profit Revenue growth/decline year-over-year 1 Generic $2.17 billion 46% $584 million -17% 2 Specialty $2.15 billion 86.9% $1.19 billion 10%
As you can see, the gross margins on those drugs make a big difference. And of the $2.15 billion in revenue from specialty drugs, about half came from Copaxone, which sold just over $1 billion in the first quarter. Profit is an even more telling story, with $808 million (or 68% of the Specialty segment's total profit) provided by Copaxone.
GLTAH.
- Forums
- ASX - By Stock
- MSB
- Called TEVA about CHF
Called TEVA about CHF, page-34
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.06 |
Change
0.030(2.91%) |
Mkt cap ! $1.210B |
Open | High | Low | Value | Volume |
$1.05 | $1.09 | $1.03 | $5.796M | 5.430M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 15990 | $1.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.08 | 48632 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 15990 | 1.060 |
3 | 33766 | 1.055 |
2 | 38526 | 1.050 |
4 | 79050 | 1.045 |
3 | 54455 | 1.040 |
Price($) | Vol. | No. |
---|---|---|
1.075 | 48632 | 3 |
1.080 | 108135 | 6 |
1.085 | 103276 | 9 |
1.090 | 239204 | 9 |
1.095 | 74283 | 8 |
Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |